(Date:12/2/2009)..., COPENHAGEN, Dec. 2 The world,...oIsoprene technology, a breakthrough alternative t... the manufacture of synthetic rubber with renewabl..., this week. One tire will be on display at a loun...International Airport throughout December 21, whil...
(Date:12/2/2009)..., LIBREVILLE, Gabon, December 2 /PRNewswire...ca: Everyone,s Problem and Heritage" , Co...ty, 2-3 June 2010 the,Gabonese Republic is hosting... on the issue of safeguarding biological resources...ernment and state leaders, ministers,scientific e...
(Date:12/2/2009)... , JERUSALEM, Israel, December 2 /PRNe...ty study evaluating the preclinical (animal study)...ch combines technology from Weill,Cornell Medical ...ntial to,treat inherited anemias such as Cooley,s ...ies of technologies to expand, ex vivo,population...
(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire-Asia...e "Company") (NYSE: SCR ), a leading pharmaceuti...acturing, and marketing of branded,generic and pro... that 105 of,its drugs have been included in China...h was issued by China,s Ministry of Human Resource...
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3...ate Growth of Pain Franchise, FRAZER, Pa., Aug. 2...t has signed an agreement to acquire the North,Ame...oride extended-release,capsules) from ECR Pharmace...ngths of AMRIX (15 mg and 30 mg) were approved in ...tion (FDA) for short-term use as an adjunct to,res...
...nBio Pharma,Inc. (OTC Bulletin Board: APNB) an eme...development of novel drugs and diagnostics for ani...o list its common stock on the,NASDAQ Capital Mark... anticipates its shares of common stock will begin... of trading on Tuesday, August 28,2007, under the ...
...ssful GAMMAGARD LIQUID and GAMMAGARD S/D, [Immune ...neered by Baxter, DEERFIELD, Ill., Aug. 22 Baxte... that it will launch GARDian, an innovative,progra... relying on,GAMMAGARD LIQUID and GAMMAGARD S/D [Im...oducts like GAMMAGARD LIQUID and GAMMAGARD S/D are...
Other Biology Technology:Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant 2Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant 3Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant 4AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY' 2AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY' 3AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY' 4Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 2Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 3Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 4Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 5Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 6Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 7Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 8Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 9...nd PowerPac basic power supply are used for submer...s in agarose gels. The Mini-Sub cell GT cell inclu... a 7 x 7 cm UV-transparent gel tray with fluoresce...height combs (8- and 15-well). The PowerPac basic ...
...owerPac basic power supply are used for submerged ... agarose gels. This Model 96 cell includes a buffe...fluorescent ruler, and a gel caster. The PowerPac ...s output of 10-300 V, 4-400 mA, and 75 W. Power co...
...PowerPac basic power supply are used for submerged...n agarose gels. This Model 192 cell includes a buf...h fluorescent ruler, and a gel caster. The PowerPa...des output of 10-300 V, 4-400 mA, and 75 W. Power ...
...ac 3000 system, 220-240 V, is used for nucleic aci...format. The system includes the modular Sequi-Gen ...ating nucleic acids with single base-pair resoluti...sembly (IPC and bonded inner glass plate, outer gl...
Biology Products: